Transcranial magnetic stimulators (TMS) are a non-invasive method of brain stimulation that utilizes electromagnetic induction to conduct research and deliver therapeutic treatment.
The medical device contains an insulated coil which generates brief magnetic pulses that pass painlessly through the skull and into the brain. When used for therapeutic means, these pulses are repeated multiple times to produce longer lasting changes. These pulses are delivered approximately once per second for thirty minutes to an hour multiple times a week. While one pulse per second is often used, devices are capable of reaching higher rates. This treatment is generally referred to as repetitive transcranial magnetic stimulation (rTMS) and it has been tested as a means to treat a variety of neurological and psychiatric disorders.
General Report Contents
• Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
• Market Drivers & Limiters for each chapter segment
• Competitive Analysis for each chapter segment
• Section on recent mergers & acquisitions
This market contains diagnostic, clinical and research units. The majority of the install base is currently research units since therapeutic clearance only occurred in the past decade in Europe. The majority of growth in unit sales over the projected period will therefore be clinical units. Growth in unit sales of research units will not be as high.
The largest market is currently Germany with larger markets in France, United Kingdom and Italy as well. These areas have higher populations and also conduct more research. Certain companies also charge a premium compared therefore all of these aspects should be considered in the ASP. The ASP will not grow significantly over the forecast period as new competitors tend to introduce competitive pricing. Positive reimbursement trends will continue which will encourage prices to stay relatively high. Research units therefore may become less expensive whereas clinical units will grow in ASP with reimbursement. All of these factors combined will make the ASP fairly stable.
'
TABLE OF CONTENTS I
LIST OF FIGURES IX
LIST OF CHARTS X
EXECUTIVE SUMMARY 1
EUROPEAN NEUROMODULATION, NEUROVASCULAR, NEUROSURGICAL AND MONITORING DEVICE MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 3
MARKET TRENDS 7
MARKET DEVELOPMENTS 10
MARKETS INCLUDED 11
PROCEDURES INCLUDED 12
KEY REPORT UPDATES 13
VERSION HISTORY 13
RESEARCH METHODOLOGY 14
1.1 RESEARCH SCOPE 14
1.2 IDATA’S 9-STEP METHODOLOGY 14
Step 1: Project Initiation & Team Selection 14
Step 2: Prepare Data Systems and Perform Secondary Research 16
Step 3: Preparation for Interviews & Questionnaire Design 17
Step 4: Performing Primary Research 18
Step 5: Research Analysis: Establishing Baseline Estimates 20
Step 6: Market Forecast and Analysis 21
Step 7: Identify Strategic Opportunities 23
Step 8: Final Review and Market Release 24
Step 9: Customer Feedback and Market Monitoring 25
DISEASE OVERVIEW 26
2.1 BASIC ANATOMY 26
2.2 DISEASE PATHOLOGY AND DISORDERS 28
2.2.1 Introduction 28
2.2.2 General Diagnostics and Neurosurgery 30
2.2.3 Tumor and Brain Cancer 32
2.2.4 Brain Arteriovenous Malformations 34
2.2.5 Ischemic Stroke 35
2.2.6 Brain Aneurysm 36
2.2.7 Disorders Related to Cerebrospinal Fluids and Intracranial Pressure 38
2.2.7.1 Hydrocephalus and Intracranial Pressure Disorder 38
2.2.7.2 Cerebral Edema 39
2.2.8 Indication for Neuromodulation 41
2.2.9 Traumatic brain injury 43
COUNTRY PROFILES 44
3.1 INTRODUCTION 44
3.1.1 Population 44
3.1.2 GDP Per Capita 44
3.1.3 Price Index 44
3.2 GERMANY 45
3.3 FRANCE 46
3.4 UNITED KINGDOM 47
3.5 ITALY 48
3.6 SPAIN 49
3.7 BENELUX 50
3.8 SCANDINAVIA 51
3.9 AUSTRIA 52
3.10 SWITZERLAND 53
3.11 PORTUGAL 54
TRANSCRANIAL MAGNETIC STIMULATOR MARKET 55
4.1 INTRODUCTION 55
4.2 MARKET ANALYSIS AND FORECAST 57
4.2.1.1 Installed Base 59
4.3 DRIVERS AND LIMITERS 60
4.3.1 Market Drivers 60
4.3.2 Market Limiters 60
4.4 COMPETITIVE MARKET SHARE ANALYSIS 62
ABBREVIATIONS 66
APPENDIX: COMPANY PRESS RELEASES 69
Chart 1 1: Neurological Device Market by Segment, Europe, 2013 – 2023 2
Chart 1 2: Neurological Device Market Overview, Europe, 2013 &2023 2
Chart 3 1: Country Profile, Germany, 2016 45
Chart 3 2: Country Profile, France, 2016 46
Chart 3 3: Country Profile, United Kingdom, 2016 47
Chart 3 4: Country Profile, Italy, 2016 48
Chart 3 5: Country Profile, Spain, 2016 49
Chart 3 6: Country Profile, Benelux, 2016 50
Chart 3 7: Country Profile, Scandinavia, 2016 51
Chart 3 8: Country Profile, Austria, 2016 52
Chart 3 9: Country Profile, Switzerland, 2016 53
Chart 3 10: Country Profile, Portugal, 2016 54
Chart 4 1: Transcranial Magnetic Stimulator Market, Europe, 2013 – 2023 58
Chart 4 2: Leading Competitors, Transcranial Magnetic Stimulator Market, Europe, 2016 65
Medtronic
Stryker
Codman & Shurtleff, Inc.
St. Jude Medical
Nevro
Carl Zeiss
Boston Scientific
LivaNova
Terumo MicroVention
Penumbra Inc.
Leica
Integra LifeSciences
BrainLab
Balt
Magstim
Phenox
MagVenture
Elekta
Moëller Wedel
Misonix
Sophysa
Aesculap
MAG & More
Neurosoft
Acandis
Soring
Brainsway
Nexstim
Others include: ANT, Asahi Intecc, Axonics, Blockade, Dispomedica, Enteromedics, Flowonix, Inomed, Intrapace, Kaneka Medical Products, MHT, Micrus Endovascular, MRC, Navimetric, Neuravi, Neuronetics, Neuropace, NextGen Medicla System, Nuvectra, Scientia Vascular, Spiegelberg, Stimwave, Tokai Medical Product, Tricumed, Vascular Solutions, etc.
